Billing for COVID-19 convalescent plasma treatment

Pursuant to a recent FDA emergency approval of COVID-19 convalescent plasma treatment with high titers of anti-SARS-CoV-2 antibodies, the CMS has authorized this service for coverage. Effective December 28, 2021, the HCPCS code C9507 must be used to report this treatment in an outpatient setting.

You need to be logged in to view the rest of the content. Please . Not a Member? Join Us

Discover more from Doctor Trusted

Subscribe to get the latest posts sent to your email.

Discover more from Doctor Trusted

Subscribe now to keep reading and get access to the full archive.

Continue reading